- The Issue
- The Solutions
- News & Media
- Case Studies
- Policy Center
An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
For journalists and other media professionals
As the health reform debate continues to the Senate, it’s important to keep the focus on the patient. This is one of the points highlighted in Politico’s health care issue last week.
Will government-supported comparative effectiveness research (CER) come between doctors and patients in making treatment decisions? The jury, I think, is still out.
We all can agree, as stated in a recent blog post by the Center for American Progress (CAP), that the goal of CER is to "permit patients and their health providers to make better decisions about care based on evidence."
Despite recent media accounts, PIPC is decidedly not an "anti-reform" group. We are pro-reform, and we were established to promote sound, patient-centered comparative effectiveness research (CER). PIPC's mission statement, adopted in 2008 when the Partnership was founded, states that PIPC is "dedicated to supporting CER that strengthens physician and patient decision making, improves health care quality, and supports continued medical progress."